Nordea Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $133M | Sell |
4,779,054
-44,112
| -0.9% | -$1.17M | 0.12% | 167 |
|
|
2025
Q4 | $120M | Sell |
4,823,166
-1,274,180
| -21% | -$32.1M | 0.1% | 190 |
|
|
2025
Q3 | $148M | Buy |
6,097,346
+167,271
| +3% | +$4.13M | 0.13% | 172 |
|
|
2025
Q2 | $144M | Buy |
5,930,075
+2,026,502
| +52% | +$47.3M | 0.13% | 178 |
|
|
2025
Q1 | $97.5M | Sell |
3,903,573
-168,127
| -4% | -$4.4M | 0.1% | 203 |
|
|
2024
Q4 | $108M | Buy |
4,071,700
+1,080,822
| +36% | +$29.3M | 0.11% | 192 |
|
|
2024
Q3 | $87M | Sell |
2,990,878
-534,961
| -15% | -$15.6M | 0.1% | 214 |
|
|
2024
Q2 | $98.6M | Sell |
3,525,839
-776,473
| -18% | -$21.4M | 0.12% | 200 |
|
|
2024
Q1 | $120M | Sell |
4,302,312
-3,907,470
| -48% | -$108M | 0.14% | 171 |
|
|
2023
Q4 | $235M | Buy |
8,209,782
+260,425
| +3% | +$7.87M | 0.3% | 95 |
|
|
2023
Q3 | $262M | Sell |
7,949,357
-415,454
| -5% | -$14.7M | 0.36% | 74 |
|
|
2023
Q2 | $304M | Buy |
8,364,811
+87,755
| +1% | +$3.42M | 0.42% | 65 |
|
|
2023
Q1 | $335M | Buy |
8,277,056
+8,737
| +0.1% | +$377K | 0.49% | 54 |
|
|
2022
Q4 | $422M | Sell |
8,268,319
-2,943,076
| -26% | -$141M | 0.66% | 35 |
|
|
2022
Q3 | $498M | Sell |
11,211,395
-988,585
| -8% | -$48M | 0.81% | 25 |
|
|
2022
Q2 | $626M | Sell |
12,199,980
-602,772
| -5% | -$30.7M | 0.93% | 25 |
|
|
2022
Q1 | $673M | Sell |
12,802,752
-257,549
| -2% | -$13.4M | 0.85% | 28 |
|
|
2021
Q4 | $775M | Buy |
13,060,301
+1,734,078
| +15% | +$85.9M | 0.93% | 23 |
|
|
2021
Q3 | $496M | Sell |
11,326,223
-46,591
| -0.4% | -$2.06M | 0.65% | 33 |
|
|
2021
Q2 | $445M | Sell |
11,372,814
-96,375
| -0.8% | -$3.75M | 0.6% | 38 |
|
|
2021
Q1 | $414M | Buy |
11,469,189
+505,540
| +5% | +$17.9M | 0.6% | 37 |
|
|
2020
Q4 | $404M | Sell |
10,963,649
-808,306
| -7% | -$29.6M | 0.65% | 37 |
|
|
2020
Q3 | $406M | Sell |
11,771,955
-11,703,157
| -50% | -$410M | 0.76% | 34 |
|
|
2020
Q2 | $719M | Buy |
23,475,112
+9,273,338
| +65% | +$315M | 0.75% | 35 |
|
|
2020
Q1 | $436M | Sell |
14,201,774
-1,573,009
| -10% | -$53.6M | 1.05% | 25 |
|
|
2019
Q4 | $582M | Sell |
15,774,783
-405,869
| -3% | -$14.5M | 1.16% | 20 |
|
|
2019
Q3 | $556M | Sell |
16,180,652
-383,608
| -2% | -$13.9M | 1.21% | 19 |
|
|
2019
Q2 | $681M | Sell |
16,564,260
-792,667
| -5% | -$31.5M | 1.52% | 11 |
|
|
2019
Q1 | $700M | Sell |
17,356,927
-352,732
| -2% | -$14.1M | 1.46% | 10 |
|
|
2018
Q4 | $734M | Sell |
17,709,659
-4,722,069
| -21% | -$196M | 1.74% | 8 |
|
|
2018
Q3 | $938M | Sell |
22,431,728
-5,655,308
| -20% | -$218M | 1.93% | 6 |
|
|
2018
Q2 | $967M | Sell |
28,087,036
-207,988
| -0.7% | -$7.11M | 2.32% | 3 |
|
|
2018
Q1 | $953M | Sell |
28,295,024
-11,364
| -0% | -$391K | 2.28% | 4 |
|
|
2017
Q4 | $973M | Sell |
28,306,388
-1,236,167
| -4% | -$42.2M | 2.3% | 6 |
|
|
2017
Q3 | $1B | Buy |
29,542,555
+1,040,322
| +4% | +$33.4M | 2.4% | 5 |
|
|
2017
Q2 | $908M | Buy |
28,502,233
+232,677
| +0.8% | +$7.34M | 2.29% | 5 |
|
|
2017
Q1 | $918M | Sell |
28,269,556
-1,125,192
| -4% | -$35.5M | 2.43% | 7 |
|
|
2016
Q4 | $906M | Sell |
29,394,748
-514,981
| -2% | -$15.7M | 2.4% | 6 |
|
|
2016
Q3 | $961M | Buy |
29,909,729
+827,798
| +3% | +$27.7M | 2.49% | 7 |
|
|
2016
Q2 | $972M | Buy |
29,081,931
+1,342,746
| +5% | +$42.9M | 2.71% | 6 |
|
|
2016
Q1 | $780M | Buy |
27,739,185
+2,671,194
| +11% | +$76.3M | 2.35% | 5 |
|
|
2015
Q4 | $768M | Sell |
25,067,991
-408,081
| -2% | -$12.8M | 2.61% | 4 |
|
|
2015
Q3 | $759M | Buy |
25,476,072
+822,640
| +3% | +$26.4M | 2.8% | 2 |
|
|
2015
Q2 | $784M | Buy |
24,653,432
+460,197
| +2% | +$15M | 2.75% | 2 |
|
|
2015
Q1 | $799M | Buy |
24,193,235
+1,031,665
| +4% | +$32.8M | 2.87% | 2 |
|
|
2014
Q4 | $685M | Buy |
23,161,570
+1,911,555
| +9% | +$54.8M | 2.53% | 2 |
|
|
2014
Q3 | $596M | Buy |
21,250,015
+565,145
| +3% | +$15.9M | 2.39% | 3 |
|
|
2014
Q2 | $582M | Buy |
20,684,870
+688,131
| +3% | +$19.6M | 2.43% | 3 |
|
|
2014
Q1 | $609M | Buy |
19,996,739
+355,372
| +2% | +$10.6M | 2.84% | 2 |
|
|
2013
Q4 | $571M | Buy |
19,641,367
+367,130
| +2% | +$10.7M | 2.84% | 2 |
|
|
2013
Q3 | $525M | Buy |
19,274,237
+857,084
| +5% | +$23.3M | 2.93% | 3 |
|
|
2013
Q2 | $489M | Buy |
+18,417,153
| New | +$509M | 3.04% | 2 |
|
Other funds holding PFE
VCM
VPM
Nordea Investment Management's PFE Position: Q1 2026 in Review
Nordea Investment Management reduced its Pfizer (PFE) stake by 0.91% in Q1 2026, selling an estimated $1.17M and leaving 4,779,054 shares worth $133M. The position accounts for 0.12% of the portfolio, ranked #167.
Nordea Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1B in Q3 2017. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Nordea Investment Management held 4,779,054 shares of Pfizer worth $133M as of Q1 2026.
- Nordea Investment Management sold 44,112 Pfizer shares in Q1 2026, an estimated $1.17M.
- Pfizer made up 0.12% of Nordea Investment Management's portfolio in Q1 2026, its #167 holding.
- Nordea Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Nordea Investment Management's Pfizer position peaked at $1B in Q3 2017.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.